EUTOS Score for Chronic Myelogenous Leukemia (CML)

Predict outcomes after CML treatment, adjusted for tyrosine kinase treatments


The EUTOS Score was derived from a cohort of 2060 patients enrolled in studies of first-line treatment with imatinib-based regimens. The EUTOS score using the percentage of basophils and spleen size best discriminated between high-risk and low-risk groups of patients, with a positive predictive value of not reaching a CCgR of 34%.


Hasford J, Baccarani M, Hoffmann V, Guilhot J, Saussele S, Rosti G, Guilhot F, Porkka K, Ossenkoppele G, Lindoerfer D, Simonsson B, Pfirrmann M, Hehlmann R.

Predicting Complete Cytogenetic Response and Subsequent Progression-Free Survival in 2060 Patients With CML on Imatinib Treatment: The EUTOS Score.

2011 Jul 21;118(3):686-92. doi: 10.1182/blood-2010-12-319038. Epub 2011 May 2.

The EUTOS Score for Chronic Myelogenous Leukemia (CML) calculator is created by QxMD.

Created by on 12/06/2016

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

1. Basophils

0/2 completed